1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. GLOBAL LIPID MARKET BY TYPE
5.1. Introduction
5.2. Fatty Acid
5.3. Glycerolipids
5.4. Phospholipids
5.5. Sphingolipids
6. GLOBAL LIPID MARKET BY SOURCE
6.1. Introduction
6.2. Plant-Based
6.3. Animal-Based
7. GLOBAL LIPID MARKET BY APPLICATION
7.1. Introduction
7.2. Food & Beverage
7.3. Pharmaceuticals
7.4. Others
8. GLOBAL LIPID MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. By Type
8.2.2. By Source
8.2.3. By Application
8.2.4. By Country
8.2.4.1. USA
8.2.4.2. Canada
8.2.4.3. Mexico
8.3. South America
8.3.1. By Type
8.3.2. By Source
8.3.3. By Application
8.3.4. By Country
8.3.4.1. Brazil
8.3.4.2. Argentina
8.3.4.3. Others
8.4. Europe
8.4.1. By Type
8.4.2. By Source
8.4.3. By Application
8.4.4. By Country
8.4.4.1. Germany
8.4.4.2. France
8.4.4.3. United Kingdom
8.4.4.4. Spain
8.4.4.5. Others
8.5. Middle East and Africa
8.5.1. By Type
8.5.2. By Source
8.5.3. By Application
8.5.4. By Country
8.5.4.1. Saudi Arabia
8.5.4.2. UAE
8.5.4.3. Others
8.6. Asia Pacific
8.6.1. By Type
8.6.2. By Source
8.6.3. By Application
8.6.4. By Country
8.6.4.1. China
8.6.4.2. India
8.6.4.3. Japan
8.6.4.4. South Korea
8.6.4.5. Indonesia
8.6.4.6. Thailand
8.6.4.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Cargill Incorporated
10.2. BASF SE
10.3. Solutex
10.4. ADM
10.5. DSM-Firmenich
10.6. Omega Protein Corporation (Cooke Inc.)
10.7. Croda International Plc
10.8. Evonik Industries AG
10.9. Merck KGaA
10.10. Nordic Naturals, Inc.
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES